NTI Stock Overview
Engages in the research, design, development, and manufacture of medical devices and solutions in Australia.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Neurotech International Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | AU$0.078 |
| 52 Week High | AU$0.13 |
| 52 Week Low | AU$0.031 |
| Beta | 1.83 |
| 1 Month Change | -18.75% |
| 3 Month Change | -22.00% |
| 1 Year Change | 56.00% |
| 3 Year Change | 34.48% |
| 5 Year Change | 609.09% |
| Change since IPO | -72.63% |
Recent News & Updates
Recent updates
Here's Why We're Watching Neurotech International's (ASX:NTI) Cash Burn Situation
Jan 28
We Think Neurotech International (ASX:NTI) Needs To Drive Business Growth Carefully
Oct 14Here's Why We're Not Too Worried About Neurotech International's (ASX:NTI) Cash Burn Situation
Jul 01Is Neurotech International (ASX:NTI) In A Good Position To Invest In Growth?
Jan 21Is Neurotech International (ASX:NTI) In A Good Position To Deliver On Growth Plans?
Oct 06Here's Why We're Watching Neurotech International's (ASX:NTI) Cash Burn Situation
May 18We're Not Very Worried About Neurotech International's (ASX:NTI) Cash Burn Rate
Dec 21Neurotech International (ASX:NTI) Is In A Good Position To Deliver On Growth Plans
Sep 04Need To Know: Neurotech International Limited (ASX:NTI) Insiders Have Been Selling Shares
Dec 08
Shareholder Returns
| NTI | AU Medical Equipment | AU Market | |
|---|---|---|---|
| 7D | 5.4% | 2.2% | 0.7% |
| 1Y | 56.0% | 18.2% | 7.8% |
Return vs Industry: NTI exceeded the Australian Medical Equipment industry which returned 18.2% over the past year.
Return vs Market: NTI exceeded the Australian Market which returned 7.8% over the past year.
Price Volatility
| NTI volatility | |
|---|---|
| NTI Average Weekly Movement | 9.8% |
| Medical Equipment Industry Average Movement | 9.8% |
| Market Average Movement | 9.0% |
| 10% most volatile stocks in AU Market | 17.6% |
| 10% least volatile stocks in AU Market | 3.4% |
Stable Share Price: NTI's share price has been volatile over the past 3 months.
Volatility Over Time: NTI's weekly volatility (10%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2016 | n/a | Peter James Griffiths | www.neurotechinternational.com |
Neurotech International Limited, together with its subsidiaries, engages in the research, design, development, and manufacture of medical devices and solutions in Australia. The company is focused on development and commercializing Mente platform, a platform technology to monitor and play role in home-based therapies. Its products includes Mente Autism for the diagnosis and treatment of autism.
Neurotech International Limited Fundamentals Summary
| NTI fundamental statistics | |
|---|---|
| Market cap | AU$79.36m |
| Earnings (TTM) | -AU$4.98m |
| Revenue (TTM) | AU$3.20m |
24.8x
P/S Ratio-15.9x
P/E RatioIs NTI overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| NTI income statement (TTM) | |
|---|---|
| Revenue | AU$3.20m |
| Cost of Revenue | AU$28.87k |
| Gross Profit | AU$3.18m |
| Other Expenses | AU$8.16m |
| Earnings | -AU$4.98m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.0049 |
| Gross Margin | 99.10% |
| Net Profit Margin | -155.47% |
| Debt/Equity Ratio | 0% |
How did NTI perform over the long term?
See historical performance and comparison